Ask the doctor: Does creatine improve strength in postmenopausal women?
Could you discuss the benefits of creatine supplements for older, postmenopausal women? Are there any drawbacks?
Could you discuss the benefits of creatine supplements for older, postmenopausal women? Are there any drawbacks?
Bioidentical hormones are promoted as being safer than FDA-approved hormones, but their production is not regulated and their claims of effectiveness have not yet been substantiated by long-term clinical trials.
Yhough ringing or other noise in the ears is bothersome, it is rarely indicative of a more serious health issue. There are ways to manage the condition or minimize its impact.
In a trial, annual screening for ovarian cancer did not result in fewer cases or fewer deaths.
A study of older adults who took daytime naps found that their total sleep time increased without causing daytime drowsiness.
Postpartum depression is a common condition following childbirth. Unfortunately many women who experience it do not seek treatment.
A study comparing treatments for chronic fatigue syndrome found that cognitive behavioral therapy yielded the best results, but the benefit from any of the treatments was modest.
I heard a news story about people using bath salts to get high. How is that possible? My husband and I have two teenagers. Should we talk with them about this?
A Harvard Medical School psychology instructor and author offers advice for dealing with perfectionist tendencies in a constructive way.
An experimental drug shows promise at slowing the growth of ovarian cancer, a study says. The drug is called olaparib. It blocks a natural enzyme known as PARP (Poly ADP ribose polymerase), making chemotherapy more effective. The drug was tested in a study of 65 women with ovarian cancer. The women received olaparib twice a day for 4 weeks. They were also divided into 2 groups: those who carry a gene mutation known as BRCA 1 or BRCA 2, and those who do not. The treatment was most effective in those with the gene mutation. Tumors shrank for 41% of them. It was also helpful for 24% of those without the mutation. The study appears in The Lancet. HealthDay News reported on it Aug. 21.